Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-25-000543
Filing Date
2025-01-03
Accepted
2025-01-03 18:33:57
Documents
2
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1409
2 POWER OF ATTORNEY (PUBLIC): POABERGER doc1.txt EX-24 3049
  Complete submission text file 0001127602-25-000543.txt   6017
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ATARA BIOTHERAPEUTICS, INC. 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address
Berger Dietmar (Reporting) CIK: 0001739515 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19731 | Film No.: 25508460